Angiolutions

medical devices

About

Angiolutions is a Germany-based medtech company dedicated to developing innovative therapeutic devices for vascular diseases, with a strong emphasis on abdominal aortic aneurysms (AAAs). Founded by Dr. Uwe Raaz and Dr. Isabel N. Schellinger, the company combines biomechanical, biological, and molecular research with traditional engineering to create effective device-based therapies. The flagship product is a minimally invasive medical device designed to treat small AAAs. This unique device absorbs the aortic pulse waves generated by each heartbeat, which contribute to the growth of AAAs. By shielding the aneurysm from these pulse waves, the device aims to halt aneurysm progression and prevent potentially life-threatening ruptures. Angiolutions is focused on advancing its research and development efforts, supported by seed financing from various investors.

Technologies

Outlook Microsoft Office 365 Apache Mobile Friendly WordPress.org Remote

Keywords

medical equipment manufacturing early intervention device device delivery system life-saving technology venture funding medical technology regulatory approval aortic pulse wave patent portfolio vascular surgery healthcare technology medical device vascular biomechanics minimally invasive therapy clinical research b2b patent family device innovation healthcare patent protection iso 13485 cardiovascular disease aaa progression medical research device safety medical device innovation cardiovascular patent filing medical innovation ip strategy

Location

Hanover, Lower Saxony, Germany

Related Companies

Companies in the same industry